Rhealth
rHEALTH is advancing humanity through spaceflight diagnostics and health AI, aiming to provide accessible health information anywhere. Their core innovation is a miniaturized, automated laboratory testing platform, exemplified by the rHEALTH ONE universal biomedical analyzer, which can perform various tests from a small blood sample. This technology has been successfully tested in space with NASA and has applications for terrestrial healthcare, enabling faster, better, and more personalized medical care. The company also offers the SKYE Sensor for continuous vital signs monitoring. rHEALTH has a strong focus on intellectual property with numerous patents and has received significant funding from organizations like NIH and XPRIZE. Their mission is to shift healthcare from curative to predictive, preemptive, and personalized medicine.
Rhealth
rHEALTH is advancing humanity through spaceflight diagnostics and health AI, aiming to provide accessible health information anywhere. Their core innovation is a miniaturized, automated laboratory testing platform, exemplified by the rHEALTH ONE universal biomedical analyzer, which can perform various tests from a small blood sample. This technology has been successfully tested in space with NASA and has applications for terrestrial healthcare, enabling faster, better, and more personalized medical care. The company also offers the SKYE Sensor for continuous vital signs monitoring. rHEALTH has a strong focus on intellectual property with numerous patents and has received significant funding from organizations like NIH and XPRIZE. Their mission is to shift healthcare from curative to predictive, preemptive, and personalized medicine.
TL;DR
Headquarters: Bedford, Massachusetts
Core products: rHEALTH One small-volume blood analyzer; SKYE Sensor continuous vitals monitor
Funding type: Government grants (NIH/NHLBI, RADx)
Founded: 2010
Company Overview
Problem Domain
Point-of-care diagnostics and continuous remote patient monitoring
Founded
2010
Industry
Biotechnology
Funding Track Record
Funding to advance a point-of-care COVID antigen test
5000000
Two NIH/NHLBI grants to support coagulation test development (awarded to affiliated DNA Medicine Institute)
Investor Signal
“Government research funders (NIH/NHLBI) and NASA contracts/partnerships”